Ginger Finelli

Ginger Finelli is an experienced oncology specialist currently employed at ImmunoGen, Inc. since February 2023. Previously, Ginger held multiple roles in prominent pharmaceutical companies, including Oncology Account Manager at Genmab from June 2021 to February 2023, and Associate Director of Strategic Engagement for Solid Tumors at GSK for the first half of 2021. Notable contributions at TESARO, Inc. included launching radium 223 for prostate cancer treatment, while earlier roles as Health Systems Manager and Executive Oncology Consultant at Algeta ASA involved developing hospital pathways and reimbursement strategies. Ginger's career also encompasses significant positions at Salix Pharmaceuticals, Eisai, Schering, AstraZeneca, and Bristol-Myers Squibb, focusing on specialty sales and account management in oncology and other therapeutic areas. Ginger Finelli earned a Bachelor of Arts in Anthropology from California State University-Sacramento.